Zhang, Hengliang
Sen, Payel
Hamers, Jules
Sittig, Theresa
Woestenburg, Brent
Moretti, Allessandra
Dendorfer, Andreas
Merkus, Daphne http://orcid.org/0000-0002-4852-831X
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 22 December 2023
Accepted: 23 April 2024
First Online: 21 June 2024
Declarations
:
: Human heart samples were obtained at the time of transplantation by the Clinic of Cardiac Surgery, Ludwig-Maximilians-University (LMU) Hospital, Munich, Germany. The patients provided informed consent for the scientific use of the explanted tissue and the study was approved by the Ethics Committee of the Ludwigs-Maximilians-University (“New models in cardiovascular research based on myocardial tissue culture”, approved on July 4th, 2012 with the registration number 063 − 12), following the ethical standards of the 1964 Declaration of Helsinki and its later amendments. iPSC cells were derived from skin fibroblasts in the laboratory of Dr Moretti, after informed consent of the patient, and the study was approved by the Ethics Committee of the Medical Faculty of the Technical University of Munich (“Generation and characterization of patient-specific induced pluripotent stem cells” on June 23rd 2008, with registration number 2109/08), following the ethical standards of the 1964 Declaration of Helsinki and its later amendments.
: The authors have no relevant financial or non-financial interests to disclose.